The reduction in amyloid deposits from estrogen skin patch use was most apparent among women carrying the APOE e4 genotype, a genetic variant associated with greater risk of late-onset Alzheimer's disease.
Notes on verification
Corroborated by multiple independent sources including press releases, news outlets, and the Mayo Clinic's academic repository, all consistently reporting the same finding. [cascade flags: aggregator_dropped_primary_exists | tier=unverified indep_score=0.3 clusters=3 claim_tier=notable] [rescored 2026-09-15: curated origin-host map (PR #65); unclassified hosts no longer scored as aggregators]
Sources
- Estrogen Patch in Newly Postmenopausal Women May Reduce ... (seed:health_and_medicine)
- https://mayoclinic.elsevierpure.com/en/publications/early-postmenopausal-transdermal-17%CE%B2-estradiol-therapy-and-amyloi/ (corroboration)
- https://www.upi.com/Health_News/2016/07/12/Estrogen-patch-may-reduce-postmenopausal-Alzheimers-risk-study-says/4671468353536 (corroboration)
- https://www.j-alz.com/content/estrogen-patch-newly-postmenopausal-women-may-reduce-alzheimer%E2%80%99s-risk (corroboration)